Abstract : The main goal of this study was to determine the prevalence and duration of acute loss of smell and taste in COVID-19 patients who visit Anwar Hospital, Saidu Sharif Swat. Initially, acute loss of smell (anosmia) and taste (ageusia) was not thought to be significant COVID-19 symptoms. To find out how often certain symptoms are and how important they are in terms of diagnosis. Cross-sectional retrospective study was conducted at Anwar Hospital, Anwar Clinical Laboratory, Saidu Sharif Swat, KPK, Pakistan from 01 March 2020 to 18 September 2021. A total of 3537 specimens of the suspected COVID-19 patients were tested using Real-Time Polymerase Chain Reaction (RT-PCR). In the current study it was found that 4.8% (45) patients had a loss of taste and smell. The patients were under observation for a duration of 2-3 weeks (8 to 21 days). The RT-PCR of 970 patients was positive whereas of 1567 was negative. The prevalence of COVID-19 was 38.23%. All participants' ages ranging from 9 to 70 years were included in this study. Ageusia and Anosmia appear to be key symptoms and indicators for COVID-19 diagnosis, especially when the illness is in its early stages. Majority of the COVID-19 patients, who had anosmia or ageusia recovered in three weeks. For both symptoms, the median duration to recovery was 7 days. In individuals with suspected COVID-19, these symptoms might be a valuable tool for early diagnostic work-up.